Morphine / Opiates Strips
Morphine is the original compound from which the classes of pharmaceuticals known as opiates and opioids originate. Codeine, oxycodone, and hydrocodone all have a chemical lineage related to morphine. This class of drugs is highly addictive, and opiate dependence among recreational or unsupervised users develops rapidly.
Morphine is among the most commonly used opiates, along with oxycodone, codeine, and hydrocodone. Standard urine drug tests are incapable of detecting morphine addiction apart from other opiates included on immunoassay panels. To overcome the limitations, 12 Panel Medical has designed a urine test strip for morphine that is accurate within 1%.
Available in bulk quantities, opiate/morphine drug tests comply with SAMHSA guidelines for cutoff concentrations in immunoassay drug screening tests. Opiate/morphine drug tests are intended for clinical settings, such as primary care offices requiring patient prescription monitoring as well as rehabilitation facilities enforcing zero-tolerance policies in cases of opiate or morphine addiction. With qualitative, easy to understand results delivered in under five minutes, these testing strips can be operated in-home and in the workplace when necessary.
Morphine and its brand name derivatives such as Avinza, Morphabond, Kadian, Oramorph, and Roxanol, are classified as Schedule II drugs that have medical value but also high potential for abuse. The active compounds found in opiates like morphine bind to the human central nervous system to illicit pain-relieving affects. Highly effective and with almost immediate analgesic affects, users can quickly develop a physical and psychological opiate dependence.
Standard paneled drug tests can test for abuse of opiates, but, as qualitative analysis methods only, they cannot report what opiate is being abused. Urine test strips capable of identifying parent drugs and their metabolites are particularly useful in screening for drug abuse, monitoring substance abuse, and monitoring compliance for court-ordered purposes. 12 Panel Medical opiate urine test strips are capable of detecting several opiate parent drugs and their metabolites including:
With the exception of 6-MAM, immunoassay urine test strips are 99% accurate in detecting parent drugs and metabolites as long as three days after ingestion. 6-MAM can be detected for less than one day after consumption, as it is extensively and rapidly metabolized by the liver.
All 12 Panel Medical urine drug test strips are compliant with SAMHSA guidelines for cutoff concentration levels for opiates, the industry-standard for determining positive and negative results in immunoassay urine drug screen tests. Expressed in nanograms per milliliter, the cut off concentrations in our opiate drug screen test is 300 ng/ml for morphine but can be adjusted where zero tolerance policies are in force.
A sample urine specimen must be collected from the donor for testing. When the urine specimen is ready for testing, the operator will remove the test strip from the protective packaging.
The testing strip may be damaged by extended exposure to light and air. Do not remove the strip until ready to perform the test to ensure the most reliable results. If the testing strip was removed from packaging more than 1 hour prior to testing, the results should not be interpreted.
Do not touch the strip membrane. Bacteria from hands and surfaces may contaminate the testing strip and invalidate results.
Hold the test strip where the product name is printed. Carefully place the testing strip membrane into the cup, in a vertical position. Do not immerse the strip past the MAX line on the testing strip.
Allow the strip to absorb as much of the sample as possible, immersing the membrane in the specimen for at least 10 to 15 seconds. You might notice color moving across the strip, but the results cannot be read before five minutes. Do not interpret results after 10 minutes.
If the specimen contains more than the pre-determined cutoff levels, the result is positive. This is indicated by one colored band in the control region and no colored band in the test region. Positive results should be sent to a toxicology laboratory for confirmation.
A negative result is indicated by one colored band in the control region, and one colored band in the test region. A negative result indicates that the specimen does not reach the cutoff levels.
If no colored band appears in the control indicator of the test strip, the result is invalid. The test must be performed again. If the problem persists, you may contact your local distributor.